boswellic acid has been researched along with camptothecin in 4 studies
| Studies (boswellic acid) | Trials (boswellic acid) | Recent Studies (post-2010) (boswellic acid) | Studies (camptothecin) | Trials (camptothecin) | Recent Studies (post-2010) (camptothecin) |
|---|---|---|---|---|---|
| 227 | 15 | 147 | 13,002 | 2,229 | 5,391 |
| Protein | Taxonomy | boswellic acid (IC50) | camptothecin (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.05 | |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 7.4 | |
| DNA topoisomerase 1 | Homo sapiens (human) | 1.9799 | |
| Somatostatin receptor type 1 | Homo sapiens (human) | 0.0022 | |
| Somatostatin receptor type 2 | Homo sapiens (human) | 0.0022 | |
| Somatostatin receptor type 4 | Homo sapiens (human) | 0.0022 | |
| Somatostatin receptor type 3 | Homo sapiens (human) | 0.0022 | |
| Somatostatin receptor type 5 | Homo sapiens (human) | 0.0022 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.97 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.05 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 9 | Homo sapiens (human) | 0.05 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.05 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, P; Kumar, A; Qazi, GN; Saxena, AK; Sethi, VK; Shah, BA; Sharma, M; Singh, J; Taneja, SC | 1 |
| Chib, R; Kaur, R; Kaur, T; Khan, S; Shah, BA; Sharma, PR; Singh, J; Taneja, SC | 1 |
| Hamid, A; Kumar, A; Saxena, AK; Sethi, VK; Shah, BA; Singh, J; Singh, S; Singh, SK; Taneja, SC | 1 |
| Badmaev, V; Duan, RD; Liu, JJ; Nilsson, A; Oredsson, S; Zhao, WZ | 1 |
4 other study(ies) available for boswellic acid and camptothecin
| Article | Year |
|---|---|
Cytotoxic and apoptotic activities of novel amino analogues of boswellic acids.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Boswellia; Cell Line, Tumor; DNA Fragmentation; Growth Inhibitors; Humans; Triterpenes | 2007 |
A comparative study of proapoptotic potential of cyano analogues of boswellic acid and 11-keto-boswellic acid.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; HeLa Cells; HL-60 Cells; Humans; Nitriles; Oxygen; Triterpenes | 2011 |
Acyl derivatives of boswellic acids as inhibitors of NF-κB and STATs.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Flow Cytometry; HL-60 Cells; Humans; Models, Chemical; NF-kappa B; Phosphorylation; STAT Transcription Factors; Triterpenes | 2012 |
Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells.
Topics: Anti-Inflammatory Agents; Apoptosis; Blotting, Western; Boswellia; Camptothecin; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Division; Cell Line; Cell Survival; Cytoplasm; DNA; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Fas Ligand Protein; fas Receptor; Flow Cytometry; Histones; Humans; Membrane Glycoproteins; Poly(ADP-ribose) Polymerases; Protein Binding; Signal Transduction; Time Factors; Triterpenes; Tumor Cells, Cultured | 2002 |